Home Cart 0 Sign in  
X

[ CAS No. 15042-01-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 15042-01-0
Chemical Structure| 15042-01-0
Chemical Structure| 15042-01-0
Structure of 15042-01-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 15042-01-0 ]

Related Doc. of [ 15042-01-0 ]

Alternatived Products of [ 15042-01-0 ]

Product Details of [ 15042-01-0 ]

CAS No. :15042-01-0 MDL No. :MFCD00010552
Formula : C9H12O6 Boiling Point : -
Linear Structure Formula :- InChI Key :POXUQBFHDHCZAD-MHTLYPKNSA-N
M.W : 216.19 Pubchem ID :54691418
Synonyms :
Chemical Name :(R)-5-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-3,4-dihydroxyfuran-2(5H)-one

Calculated chemistry of [ 15042-01-0 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 1
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 47.31
TPSA : 85.22 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.01
Log Po/w (XLOGP3) : -0.27
Log Po/w (WLOGP) : 0.39
Log Po/w (MLOGP) : -1.19
Log Po/w (SILICOS-IT) : 0.21
Consensus Log Po/w : 0.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -0.94
Solubility : 24.6 mg/ml ; 0.114 mol/l
Class : Very soluble
Log S (Ali) : -1.06
Solubility : 18.8 mg/ml ; 0.087 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.06
Solubility : 189.0 mg/ml ; 0.873 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.98

Safety of [ 15042-01-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 15042-01-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 15042-01-0 ]
  • Downstream synthetic route of [ 15042-01-0 ]

[ 15042-01-0 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
YieldReaction ConditionsOperation in experiment
89% With trichlorophosphate In acetone at 20℃; for 4 h; To a magnetically stirred solution of AA (1.76 g, 10 mmol) in acetone (9 mL), phosphorus oxychloride (0.5 mL) was added and the reaction mixture was stirredfor 4 h at RT. Then it was filtered, washed with cold acetone–water and dried invacuo, leading to 5,6-O-isopropylidene-L-ascorbic acid 19 being obtained as colorless granules (1.92 g, 89percent). IR (KBr, cm-1): νmax 3242.6, 2993.3, 2907.6, 2741.6, 1755.5, 1665.4. 1H NMR (600 MHz, CD3COCD3): δ 4.71–4.73 (m, 1H, C4-H), 4.37–4.39 (m, 1H, C5-H), 4.16–4.21 (m, 1H, C6-H), 3.99–4.03 (m, 1H, C6-H), 1.29 (s, 6H, Me).
Reference: [1] Research on Chemical Intermediates, 2017, vol. 43, # 10, p. 5901 - 5916
[2] Chemische Berichte, 1936, vol. 69, p. 879
[3] Nature (London, United Kingdom), 1932, vol. 130, p. 847
[4] Justus Liebigs Annalen der Chemie, 1947, vol. 558, p. 177,181
[5] Patent: US2002/156051, 2002, A1,
[6] Patent: US4999437, 1991, A,
[7] Patent: US4552888, 1985, A,
[8] Patent: EP411183, 1991, A1,
[9] Patent: EP411184, 1991, A1,
  • 2
  • [ 77-76-9 ]
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
YieldReaction ConditionsOperation in experiment
91% at 20 - 30℃; for 2 h; Inert atmosphere; Industry scale i)
5,6-O-Isopropylidene-L-Ascorbic Acid
To a mixture of L-ascorbic acid (65 kg, 369 mol), acetone (283 kg) and 2,2-dimethoxypropane (46 kg, 443 mol) was charged p-toluenesulfonic acid (1.1 kg, 5.5 mol).
Temperature was adjusted to 25±5° C.
The slurry was stirred for 2 hours, during which time nitrogen was frequently flushed through the bottom valve to prevent material from settling at the bottom of the reactor. NMR analysis (solvent: D2O) then showed 98.5percent conversion.
Heptanes (222 kg) were charged and the temperature adjusted to 5±5° C.
The reaction mixture was stirred for at least 30 minutes before filtering.
Remains of the acetonide product in the reactor were rinsed onto the filter cake using the mother liquors.
The filter cake was washed with heptanes (111 kg) and dried at 50° C. to give 5,6-O-isopropylidene-L-ascorbic acid (73 kg, 336 mol) as an almost white powder. Yield: 91percent.
1H NMR (400 MHz, d6-DMSO, with maleic acid and TFA) δ4.71 (d, J=3.0 Hz, 1H), 4.28 (m, 1H), 4.11 (dd, J=7.0, 8.4 Hz, 1H), 3.90 (dd, J=6.3, 8.4 Hz, 1H), 1.27 (s, 6H).
91% With toluene-4-sulfonic acid In acetone at 25℃; for 2 h; Inert atmosphere; Large scale To a mixture of L-ascorbic acid (65 kg, 369 mol), acetone (283 kg) and 2,2- dimethoxypropane (46 kg, 443 mol) was charged /?-toluenesulfonic acid (1.1 kg, 5.5 mol). Temperature was adjusted to 25±5°C. The slurry was stirred for 2 hours, during which time nitrogen was frequently flushed through the bottom valve to prevent material from settling at the bottom of the reactor. NMR analysis (solvent: D20) then showed 98.5 percent conversion. Heptanes (222 kg) were charged and the temperature adjusted to 5±5°C. The reaction mixture was stirred for at least 30 minutes before filtering. Remains of the acetonide product in the reactor were rinsed onto the filter cake using the mother liquors. The filter cake was washed with heptanes (111 kg) and dried at 50°C to give 5,6-O-isopropylidene-L-ascorbic acid (73 kg, 336 mol) as an almost white powder. Yield: 91percent. 1H NMR (400 MHz, d6-DMSO, with maleic acid and TFA) δ 4.71 (d, J= 3.0 Hz, 1H), 4.28 (m, 1H), 4.11 (dd, J= 7.0, 8.4 Hz, 1H), 3.90 (dd, J= 6.3, 8.4 Hz, 1H), 1.27 (s, 6H).
91% With toluene-4-sulfonic acid In acetone at 20 - 30℃; for 2 h; Inert atmosphere; Industrial scale To a mixture of L-ascorbic acid (65 kg, 369 mol), acetone (283 kg) and 2,2-dimethoxypropane (46 kg, 443 mol) was charged /p-toluenesulfonic acid (1.1 kg, 5.5 mol). Temperature was adjusted to 25±5°C. The slurry was stirred for 2 hours, during which time nitrogen was frequently flushed through the bottom valve to prevent material from settling at the bottom of the reactor. NMR analysis (solvent: D20) then showed 98.5 percent conversion. Heptanes (222 kg) were charged and the temperature adjusted to 5±5°C. The reaction mixture was stirred for at least 30 minutes before filtering. Remains of the acetonide product in the reactor were rinsed onto the filter cake using the mother liquors. The filter cake was washed with heptanes (111 kg) and dried at 50°C to give 5,6-O-isopropylidene-L-ascorbic acid (73 kg, 336 mol) as an almost white powder. Yield: 91percent. 1H NMR (400 MHz, d6-DMSO, with maleic acid and TFA) δ 4.71 (d, J= 3.0 Hz, 1H), 4.28 (m, 1H), 4.11 (dd, J= 7.0, 8.4 Hz, 1H), 3.90 (dd, J= 6.3, 8.4 Hz, 1H), 1.27 (s, 6H).
86% With camphor-10-sulfonic acid In acetone at 20℃; This material was prepared according to literature precedence (Bioorg. Med. Chem. 2003, vol. 11, 827). To a suspension of L-ascorbic acid (20.0 g, 114 mmol) in acetone (200 mL) was added 2,2-dimethoxypropane (20.4 g, 196 mmol) and 10- camphorsulfonic acid (1.32 g, 5.68 mmol). The resultant mixture was allowed to stir overnight at room temperature. To the resultant slurry was added approximately 0.6 g tri ethyl amine. A portion of hexane was added to the mixture, and the white precipitate was collected via vacuum filtration, washing with additional hexane. The material was dried under vacuum to afford the desired product (21.0 g, 86percent yield). NMR was consistent with the desired product.
82% With tin(ll) chloride In acetone for 6 h; Reflux A mixture of l-Ascorbic acid compound 1 g (2 mmol) and acetone(15 mL) was stirred for 15 min. 2,2-Dimethoxy propane(1.25 mL) and catalytic amount of tin chloride was added to thereaction mixture and it was refluxed for 6 h. Cooled the reactionmixture to 5-10 °C and stirred for 45 min at room temperature.The precipitated was filtered, washed with acetone and dried toget the compound 2A. Yield: 82percent; M.P: 206 C. TLC: 100 DCM: 20EA: 10 ethanol: 1 Acetic acid.
79% With hydrogenchloride In methanol at 20 - 25℃; for 4 h; To the solution of L-Ascorbic acid (100 g, 568 mmol) in 200 mL acetone was treated with 2,2-dimethoxypropane (118 g, 1.13 mmol), and Hydrochloric acid (4 M in methanol, 60 mL). The reaction mixture was stirred at room temperature for 4 h. the mixture was filtered and the filter cake was washed with 10 mL acetone and dried in vacuum to afford 37 (90 g, 79percent) as a white solid.
50 mg With hydrogenchloride In acetone at 25 - 30℃; for 4 h; A mixture of L-Ascorbic acid compound of formula-3 (50 gm) and acetone (250 ml) was stirred for 15 minutes. 2,2-Dimethoxy propane (62.5 ml) was added to the reaction mixture. Acidified the reaction mixture by using HCl gas and stirred for 4 hrs at 25-30°C. Cooled the reaction mixture to 5-10°C and stirred for 45 minutes at the same temperature. The precipitated solid was filtered, washed with acetone and dried to get the title compound. Yield: 50 gm; M.R: 205-210°C.

Reference: [1] Tetrahedron Asymmetry, 1997, vol. 8, # 14, p. 2299 - 2302
[2] Tetrahedron Letters, 2002, vol. 43, # 2, p. 213 - 216
[3] Journal of Organic Chemistry, 1985, vol. 50, # 19, p. 3462 - 3467
[4] Tetrahedron: Asymmetry, 1991, vol. 2, # 5, p. 359 - 362
[5] Patent: US2012/15927, 2012, A1, . Location in patent: Page/Page column 8
[6] Patent: WO2013/8002, 2013, A1, . Location in patent: Page/Page column 39
[7] Patent: EP2740458, 2016, B1, . Location in patent: Paragraph 0045
[8] Tetrahedron, 2013, vol. 69, # 9, p. 2157 - 2166
[9] Patent: WO2017/95704, 2017, A1, . Location in patent: Page/Page column 53
[10] Bioorganic Chemistry, 2019, vol. 82, p. 178 - 191
[11] European Journal of Medicinal Chemistry, 2018, vol. 151, p. 98 - 109
[12] Tetrahedron Letters, 2004, vol. 45, # 28, p. 5395 - 5398
[13] Tetrahedron Letters, 1990, vol. 31, # 7, p. 1002 - 1006
[14] Synthesis, 1995, # 6, p. 687 - 692
[15] Patent: US4567282, 1986, A,
[16] Patent: US4502994, 1985, A,
[17] Carbohydrate Research, 2009, vol. 344, # 15, p. 2100 - 2104
[18] Bulletin of the Korean Chemical Society, 2012, vol. 33, # 7, p. 2213 - 2218
[19] Patent: WO2016/207907, 2016, A1, . Location in patent: Page/Page column 18
  • 3
  • [ 75-36-5 ]
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
YieldReaction ConditionsOperation in experiment
91% at 5 - 20℃; for 22.5 h; Inert atmosphere To a solution of L-ascorbic acid 5 (20.01 g, 113.6 mmol, 1.0 eq) in acetone (80 mL) was added acetyl chloride (2.1 mL, 29.9 mmol, 0.26 eq) at room temperature. After stirring for 3.5 h at room temperature, the reaction mixture was stored in the refrigerator (5 °C) for 19 h. The solid was then filtered off and washed with a small amount of cold acetone to afford 6 as a colorless solid (22.36 g, 103.4 mmol, 91percent)
Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 52, p. 5899 - 5901
[2] Patent: US6602906, 2003, B1,
[3] Patent: US5552520, 1996, A,
[4] Patent: US5607968, 1997, A,
  • 4
  • [ 7778-85-0 ]
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
YieldReaction ConditionsOperation in experiment
95% With toluene-4-sulfonic acid In dimethyl sulfoxide; acetone at 50℃; for 5 h; Example 1
Synthesis of 5,6-O-isopropylidene Ascorbic Acid
To the mixed solvent composed of 100 mL of dimethylsulfoxide and 40 ml of acetone were added 17.6 g of L-ascorbic acid, 15.6 g of 1,2-dimethoxypropane and 1.2 g of p-tolusulfonic acid, followed by stirring for 5 hours at 50° C.
The produced reaction mixture was vacuum-distillated at 20° C. to eliminate the remaining acetone and non-reacted 1,2-dimethoxypropane to give 20.5 g of the target compound (yield: 95percent).
Reference: [1] Patent: US2010/48919, 2010, A1, . Location in patent: Page/Page column 2-3
  • 5
  • [ 67-64-1 ]
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
YieldReaction ConditionsOperation in experiment
95% With 1,2-dimethoxypropane; toluene-4-sulfonic acid In dimethyl sulfoxide at 50℃; for 5 h; To the mixed solvent composed of 100 mL of dimethylsulfoxide and 40 ml of acetone were added 17.6 g of L- ascorbic acid, 15.6 g of 1, 2-dimethoxypropane and 1.2 g of p- tolusulfonic acid, followed by stirring for 5 hours at 50 °C The produced reaction mixture was vacuum-distillated at 20 °C to eliminate the remaining acetone and non-reacted 1,2- dimethoxypropane to give 20.5 g of the target compound (yield: 95percent) .
94.4% for 4 h; Cooling with ice To a 100 mL single flask was added 3.52 g of vitamin C, 2.76 g of p-toluenesulfonic acid, 15 mL of acetone, ice bath condition 4h, The filter cake was washed with ethyl acetate and dried in vacuo to give 4.08 g of 5,6-O-isopropylidene-L-ascorbic acid as a white solid in a yield of 94.4percent.
86% at 20℃; for 3 h; Preparation Example 1 : Preparation of ---5,6-O-isopropylidin-ascorbic acid; L-5,6-O-isopropylidin-ascorbic acid was prepared according to a method disclosed in Journal of the American Chemical Society, Vol. 102, No. 20, pp 6304,1980. That is, 100 g of ascorbic acid was added to 50 ml of acetone. While the reaction mixture was stirred at room temperature, 10 ml of acetyl chloride was <n="16"/>added to the mixture, which was then stirred for 3 hours. The mixture was cooled in ice bath and filtered to isolate a precipitate. The precipitate was washed with 500 ml of cold acetone and dried under reduced pressure to obtain 105 g of L-δ.e-O-isopropylidin-ascorbic acid (yield: 86percent, mp: 206-208 °C). 1H NMR (400MHz, CDCL3), Chemical shift; 5.50 (1 H, d), 5.18 (1 H1 m),4.20(2H, t), 2.52(2H, m), 2.51 (4H, t), 2.25-1.55 (12H, m)
85% at 0℃; for 24 h; FORMATION of one of the cholesterol absorption inhibitors described herein: Disodium ASCORBYL PHOSPHATE E RRE To a dry round bottom flask, acetone (150 ML) and L-ascorbic acid (50 g) were added at 0 °C. Acetyl chloride (7.5 ML was added dropwise through an addition funnel in 10 minutes. The reaction mixture was stirred at 0 °C for 24 hours. The precipitate was filtered off and washed with acetone (3X20 ML). The white product, 5, 6-ISOPROPYLIDINE ascorbic acid, was dried under vacuum for 1.5 hours to give a dry powder (52 g), yield 85percent. A dry three neck round bottom flask was fitted with a stirring bar, argon inlet and an addition funnel. A solution of dehydroisoandrosterone (1.73 g, 6 MMOL) in anhydrous THF (15 ml) and pyridine (2.4 ml) was added dropwise to the mixture of anhydrous THF (12 ml) and POCI3 (0.7 ML, 7.5 MMOL) at 0 °C over a period of 10 minutes. A white precipitate formed immediately. The suspension was stirred at 0 °C for 40 minutes, and at room temperature for 1 hour and 40 minutes. To the above suspension, a solution of 5, 6-ISOPROPYLIDINE ascorbic acid (3.6 g, 16.67 MMOL) in anhydrous pyridine (3 ml) and THF (30 ml) was added dropwise at 0 °C over a period of 20 minutes. The suspension was stirred at 0 °C for 30 minutes, and at room temperature for 1.5 hours. The formed pyridinium chloride was filtered out and washed with THF twice. The solvents were evaporated under reduced pressure at 40 °C to afford a residue. The residue was dissolved in THF (40 ML), and 2N HCI (30 ml) was added in one portion. The mixture was stirred at room temperature for 8 hours. THF was evaporated under a reduced pressure. The water layer was extracted with ethyl acetate (4X50 ML). The combined ethyl acetate solution was washed with brine (100 ML), and dried over NA2SO4. The solvent was evaporated to give a residue. The residue was dissolved in CHCI3, and then hexanes was added to precipitate the product. The precipitated solid was filtered out, washed with hexanes and dried under vacuum (2.43 g, crude product, yield : 77percent). The purification of phosphate ester was done by reverse phase C-18 chromatography (Waters, water/methanol = 90/10 to 60/40). Pure compound 4 (Figure 1,39 mg) was isolated from 50 mg of the crude product. The overall yield (base on dehydroisoandrosterone) was 60 percent. ASCORBYL phosphate ester of dehydroisoandrosterone (0.5 g, 0.95 MMOL) was dissolved in methanol (3 ml) at room temperature, and then sodium methoxide in methanol (1ML, 20percent) was added. The suspension was stirred at room temperature for 30 minutes. The precipitated solid was filtered out, washed with methanol, acetone and hexanes. The mother liquor was concentrated to 2 mi, acetone was added to precipitate the product. An additional white solid was obtained. The combined solid was dried under vacuum at room temperature. Disodium ascorbyl phosphate ester of dehydroisoandrosterone (0.49 G, yield 91 percent) was obtained.
85% at 0℃; for 24 h; To a dry round bottom flask, acetone (150 ml) and L-ascorbic acid (50 g) were added at 0 C. Acetyl chloride (7.5 ml) was added dropwise through an addition funnel in 10 minutes. The reaction mixture was stirred at 0 C. for 24 hours. The precipitate was filtered off and washed with acetone (3x20 ml). The white product, 5,6-isopropylidine ascorbic acid, was dried under vacuum for 1.5 hours to give a dry powder (52 g), yield 85percent.
80.6% at 25℃; 250 ?l of acetyl chloride are added to a suspension of vitamin C, or ascorbic acid (3 g, 17 mmol) in 30 ml of acetone. The solution becomes clear and a white precipitate then forms. After reaction overnight, the precipitate is filtered off and then rinsed with ice-cold ethyl acetate. The powder obtained is then dried to give 2.96 g (13.7 mmol) of protected vitamin C (CV-100), i.e. an 80.6percent yield.
80% at 25 - 30℃; for 5 h; Methanesulfonic acid (13 mL, 0.200 mol) was dropwised to slurry of L-ascorbic acid (10 g, 0.568 mol) in acetone (400 mL). The mixture was stirred at 25-30° C. After 5 hours, the crystalline product separated. The crystals were collected by filtration, washed with cool acetone and dried in vacuum desiccators at 40° C. Gave 100 g of Formula I (0.463 mol; yield 80percent).
80.2% at -5 - 20℃; To a dried 1 L three-necked flask, 91.0 g of ascorbic acid and 450 mL of acetone were added. The temperature was cooled to -5° C. in an ice-salt bath; 200.0 g of concentrated sulfuric acid was dropped slowly for approximately 2.5 hours and the internal temperature of the solution was controlled to 0-5° C., stirred for 5.0 min, then the ice-salt bath was moved away; the temperature was increased naturally to room temperature, and the reaction was continued for 45 minutes; the reacting solution changed from colorless to pale yellow; then the reacting solution was subjected to vacuum filtration under reduced pressure and the filter cake was washed for several times with a small amount of acetone until the pH value was neutral; the filter cake was dried at 50° C. in a vacuum for 1-2 hours and 89.5 g of white solid powder was obtained the melting point of which is 215-217° C. The yield was 80.2percent.
74% at 20℃; 5,6-Isopropylidene-L-ascorbic acid
followed the procedure reported by Jung and Shaw (J. Am. Chem. Soc, 102 [1980] 6304). L-Ascorbic acid (10.01 g, 0.0568 mol) was added to a 125 mL Erlenmeyer flask with approximately 50 mL of acetone (0.681 mol). The slurry was stirred as 1 mL of acetyl chloride (0.0140 mol) was added. The mixture was corked, sealed with Parafilm and left to stir at room temperature for 2-3 hours. The flask was then stored in a refrigerator (7 °C) for 20-24 hours. The solid from this mixture was isolated by vacuum filtration, and was rinsed with cold acetone. After drying at room temperature, the solid weighed 9.09 g, (74percent). The identity of the solid as 5,6-isopropylidene-L-ascorbic acid was confirmed by NMR and a melting point of 202-205 °C (crude literature [J. Am. Chem. Soc, 102 (1980) 6304]: 195-200 °C); recrystallization from acetone/hexane did not improve the melting point (recrystallized literature [Can. J. Chem., 47 (1969) 2498]: 217-222 °C). 1H NMR (Me2SO-d6) δ 1.255 (6H, s), 3.882 (1H, dd, J= 8.0, 6.8 Hz), 4.098 (1H, dd, J= 7.8, 8.0 Hz), 4.2615 (1H, td, J- 2.8, 6.6 Hz), 4.7095 (1H, d, 2.8 Hz), 8.482 (1H, s), 1 1.293 (1H, s).
67.2% at 20℃; for 2 h; Ascorbic acid (4g, 22.7mmol) was suspended in 2.5ml of anhydrous acetone. A catalytic amount of acetyl chloride (1.76ml, 24.7mmol) was then added and the reaction mixture was stirred for 2 hours at room temperature using a calcium chloride drying tube. The slurry was cooled to O0C, filtered, washed with cold acetone and dried under vacuum to yield 5,6-O-isopropylidene-ascorbic acid (3.57g, yield: 67.2percent) as a white solid. <n="17"/>1H NMR (d6-DMSO) δ 1.23 (6 H, s, 2 CHJ), 3.86 - 3.88 (1 η, dd, -0-CHH-CH(O)-), 4.05 -4.09 (1 H, dd, -0-CHZZ-CH(O)-), 4.24 - 4.25 (1 H, td, -O-CH2 -CH(O)-CH-), 4.71 (1 H, d,CH2-CH(O)-CZZ(O)-), 8.43 (1 H, broad s, OH), 1 1.27 (1 η, broad s, OH).13C NMR (d6-DMS0) 6 25.53, 25.92, 64.97, 73.54, 74.36, 109.13, 1 18.28, 152.51 , 170.37MS-ESI mlz 234.09 [M + Nη4]+CHN: Found (C=49.36percent, 5.65percent), Theoretical (C=50.00percent, 5.59percent)
11.3 g at 0 - 20℃; for 3 h; To 10.1 g of ascorbic acid was added 50 ml of acetone, and the mixture was stirred. 0.85 g (0.011 mol) of acetyl chloride was added slowly at 0 °C, and the mixture was stirred at room temperature for 3 hours. The reaction solvent was removed and the residue was subjected to silica gel column chromatography with ethyl acetate and n-hexane (1: 3) to obtain 8.66 g of white solid title compound.
9.55 g at 20℃; for 3 h; As vitamin C, L-ascorbic acid (10 g, 55 mmol) manufactured by Wako Pure Chemical Industries, Ltd. was dissolved in acetone, acetyl chloride (1 ml, 15 mmol) was added, and the mixture was stirred at room temperature for 3 hours. The solid was separated by filtration, and the obtained solid was washed with acetone and then dried to obtain 5,6-isopropylidene vitamin C (aka: 5,6-isopropylidene ascorbic acid) of the chemical formula 18 (9.55 g, 44.2 mmol) was obtained as a white solid.
19.6 g With toluene-4-sulfonic acid In dimethyl sulfoxide at 25℃; for 5 h; 20.6 g of L-ascorbic acid and 1.7 g of p-toluenesulfonic acid were added to a mixed solution of 100 ml of dimethyl sulfoxide and 40 ml of acetone to prepare an ascorbic acid solution.And the mixture was stirred at 25 DEG C for 5 hours to synthesize 3-O-isopropylidene ascorbic acid in the solution. At this time, the termination time of the reaction is determined by thin layer chromatography (TLC)After the reaction was completed, the solution was dried to obtain 19.6 g of 3-O-isopropylidene ascorbic acid.

Reference: [1] Acta Chemica Scandinavica, 1995, vol. 49, # 4, p. 297 - 300
[2] Tetrahedron Letters, 2010, vol. 51, # 32, p. 4199 - 4201
[3] Tetrahedron, 2005, vol. 61, # 18, p. 4341 - 4346
[4] Patent: WO2008/44809, 2008, A1, . Location in patent: Page/Page column 9
[5] Patent: CN104370977, 2017, B, . Location in patent: Paragraph 0018
[6] European Journal of Medicinal Chemistry, 2016, vol. 110, p. 376 - 388
[7] Patent: WO2009/14343, 2009, A2, . Location in patent: Page/Page column 14-15
[8] Patent: WO2005/30225, 2005, A2, . Location in patent: Page/Page column 41
[9] Patent: US2005/234025, 2005, A1, . Location in patent: Page/Page column 15; sheet 1
[10] Journal of Medicinal Chemistry, 1988, vol. 31, # 4, p. 793 - 798
[11] Journal of the American Chemical Society, 1980, vol. 102, # 20, p. 6304 - 6311
[12] Organic Letters, 2018, vol. 20, # 18, p. 5849 - 5852
[13] Tetrahedron Letters, 1989, vol. 30, # 19, p. 2505 - 2508
[14] Patent: US2004/236098, 2004, A1, . Location in patent: Page 6
[15] Patent: US2010/56809, 2010, A1, . Location in patent: Page/Page column 3
[16] Patent: US2010/204464, 2010, A1, . Location in patent: Page/Page column 5-6
[17] Chemistry - A European Journal, 2005, vol. 11, # 8, p. 2525 - 2536
[18] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 3, p. 725 - 734
[19] Carbohydrate Research, 1996, vol. 286, p. 123 - 138
[20] Molecules, 2007, vol. 12, # 11, p. 2533 - 2545
[21] Patent: WO2015/48121, 2015, A1, . Location in patent: Paragraph 000230
[22] Medicinal Chemistry Research, 2008, vol. 17, # 2-7, p. 53 - 61
[23] Synthesis, 2011, # 4, p. 555 - 562
[24] Chinese Chemical Letters, 2013, vol. 24, # 2, p. 117 - 119
[25] Patent: WO2008/110813, 2008, A2, . Location in patent: Page/Page column 15-16
[26] Tetrahedron: Asymmetry, 1995, vol. 6, # 5, p. 1181 - 1190
[27] Organic and Biomolecular Chemistry, 2005, vol. 3, # 13, p. 2450 - 2457
[28] Synthetic Communications, 1989, vol. 19, # 20, p. 3529 - 3534
[29] Journal of Molecular Structure, 2004, vol. 687, # 1-3, p. 101 - 106
[30] Tetrahedron Asymmetry, 1998, vol. 9, # 8, p. 1359 - 1367
[31] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 13, p. 1703 - 1706
[32] Australian Journal of Chemistry, 1999, vol. 52, # 2, p. 137 - 142
[33] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 20, p. 5313 - 5316
[34] Patent: WO2005/30225, 2005, A2, . Location in patent: Page/Page column 40
[35] Patent: US2005/234025, 2005, A1, . Location in patent: Page/Page column 18; sheet 7; 8
[36] Patent: WO2009/51460, 2009, A2, . Location in patent: Page/Page column title page; 16-17
[37] Chemistry - A European Journal, 2010, vol. 16, # 43, p. 12935 - 12940
[38] Patent: US2013/102649, 2013, A1, . Location in patent: Paragraph 0251; 0252
[39] European Journal of Medicinal Chemistry, 2014, vol. 82, p. 314 - 323
[40] Patent: KR101491728, 2015, B1, . Location in patent: Paragraph 0090-0092
[41] Patent: JP2016/44171, 2016, A, . Location in patent: Paragraph 0075; 0076
[42] RSC Advances, 2017, vol. 7, # 2, p. 791 - 800
[43] Patent: KR2017/11019, 2017, A, . Location in patent: Paragraph 0116; 0123-0125
[44] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 110 - 116
[45] Patent: KR2016/143901, 2016, A, . Location in patent: Paragraph 0025; 0026; 0027; 0028; 0029
[46] Archiv der Pharmazie, 2018, vol. 351, # 5,
  • 6
  • [ 78619-96-2 ]
  • [ 67-64-1 ]
  • [ 15042-01-0 ]
Reference: [1] Patent: CN105367524, 2016, A, . Location in patent: Paragraph 0025; 0026
  • 7
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
Reference: [1] Patent: EP411182, 1991, A1,
  • 8
  • [ 75-36-5 ]
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
Reference: [1] Patent: US5536500, 1996, A,
  • 9
  • [ 814-68-6 ]
  • [ 50-81-7 ]
  • [ 15042-01-0 ]
Reference: [1] Doklady Chemistry, 1993, vol. 333, # 1-6, p. 290 - 292[2] Dokl. Akad. Nauk SSSR Ser. Khim., 1993, vol. 333, # 5, p. 730 - 731
  • 10
  • [ 216872-53-6 ]
  • [ 15042-01-0 ]
Reference: [1] Australian Journal of Chemistry, 1999, vol. 52, # 2, p. 137 - 142
  • 11
  • [ 15042-01-0 ]
  • [ 23735-43-5 ]
Reference: [1] Tetrahedron: Asymmetry, 1995, vol. 6, # 5, p. 1181 - 1190
[2] Tetrahedron: Asymmetry, 1995, vol. 6, # 5, p. 1181 - 1190
[3] Journal of the American Chemical Society, 1980, vol. 102, # 20, p. 6304 - 6311
  • 12
  • [ 15042-01-0 ]
  • [ 137-66-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 20, p. 5313 - 5316
  • 13
  • [ 15042-01-0 ]
  • [ 60456-21-5 ]
Reference: [1] Synthesis, 1988, # 1, p. 54 - 56
  • 14
  • [ 15042-01-0 ]
  • [ 86404-04-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1992, vol. 35, # 9, p. 1618 - 1623
[2] Patent: CN105367524, 2016, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 15042-01-0 ]

Alcohols

Chemical Structure| 89-65-6

[ 89-65-6 ]

(R)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one

Similarity: 0.88

Chemical Structure| 86404-04-8

[ 86404-04-8 ]

(R)-5-((S)-1,2-Dihydroxyethyl)-4-ethoxy-3-hydroxyfuran-2(5H)-one

Similarity: 0.84

Chemical Structure| 28664-35-9

[ 28664-35-9 ]

3-Hydroxy-4,5-dimethylfuran-2(5H)-one

Similarity: 0.68

Chemical Structure| 23094-69-1

[ 23094-69-1 ]

(52R,53S,54R,55S,56S)-14,15,16,24,25,26,53,55-Octahydroxy-3,8-dioxo-53,54,55,56-tetrahydro-52H-4,7-dioxa-5(4,2)-pyrana-1,2(1,2)-dibenzenacyclooctaphane-56-yl 3,4,5-trihydroxybenzoate

Similarity: 0.67

Chemical Structure| 113170-55-1

[ 113170-55-1 ]

Trimagnesium bis((R)-5-((S)-2-hydroxy-1-oxidoethyl)-4-oxido-2-oxo-2,5-dihydrofuran-3-yl phosphate)

Similarity: 0.66

Esters

Chemical Structure| 89-65-6

[ 89-65-6 ]

(R)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one

Similarity: 0.88

Chemical Structure| 86404-04-8

[ 86404-04-8 ]

(R)-5-((S)-1,2-Dihydroxyethyl)-4-ethoxy-3-hydroxyfuran-2(5H)-one

Similarity: 0.84

Chemical Structure| 28664-35-9

[ 28664-35-9 ]

3-Hydroxy-4,5-dimethylfuran-2(5H)-one

Similarity: 0.68

Chemical Structure| 23094-69-1

[ 23094-69-1 ]

(52R,53S,54R,55S,56S)-14,15,16,24,25,26,53,55-Octahydroxy-3,8-dioxo-53,54,55,56-tetrahydro-52H-4,7-dioxa-5(4,2)-pyrana-1,2(1,2)-dibenzenacyclooctaphane-56-yl 3,4,5-trihydroxybenzoate

Similarity: 0.67

Chemical Structure| 113170-55-1

[ 113170-55-1 ]

Trimagnesium bis((R)-5-((S)-2-hydroxy-1-oxidoethyl)-4-oxido-2-oxo-2,5-dihydrofuran-3-yl phosphate)

Similarity: 0.66

Related Parent Nucleus of
[ 15042-01-0 ]

Furans

Chemical Structure| 89-65-6

[ 89-65-6 ]

(R)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one

Similarity: 0.88

Chemical Structure| 86404-04-8

[ 86404-04-8 ]

(R)-5-((S)-1,2-Dihydroxyethyl)-4-ethoxy-3-hydroxyfuran-2(5H)-one

Similarity: 0.84

Chemical Structure| 28664-35-9

[ 28664-35-9 ]

3-Hydroxy-4,5-dimethylfuran-2(5H)-one

Similarity: 0.68

Chemical Structure| 113170-55-1

[ 113170-55-1 ]

Trimagnesium bis((R)-5-((S)-2-hydroxy-1-oxidoethyl)-4-oxido-2-oxo-2,5-dihydrofuran-3-yl phosphate)

Similarity: 0.66

Chemical Structure| 13137-64-9

[ 13137-64-9 ]

4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-Dihydroxy-3-(((2R,4S,5R,6R)-4-methoxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

Similarity: 0.60

Dioxolanes

Chemical Structure| 51656-91-8

[ 51656-91-8 ]

Ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate

Similarity: 0.63

Chemical Structure| 93635-76-8

[ 93635-76-8 ]

(2S,3R)-Ethyl 3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate

Similarity: 0.55

Chemical Structure| 78086-72-3

[ 78086-72-3 ]

(4R,5S)-Methyl 2,2,5-trimethyl-1,3-dioxolane-4-carboxylate

Similarity: 0.53

Chemical Structure| 6413-10-1

[ 6413-10-1 ]

Ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate

Similarity: 0.51

Chemical Structure| 1489-97-0

[ 1489-97-0 ]

Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate

Similarity: 0.50